Search
Neumora Therapeutics Inc
NMRAAdd to Watchlist
0.429USD
-0.004-0.92%
Close 11-13 16:00（ET）
80.61MMarket Cap
LossP/E TTM
After-hours 16:01 (ET)0.440USD+0.012+2.80%
After-hours 16:01 (ET)Today
-0.92%
5 Days
-14.71%
1 Month
+20.85%
6 Months
-78.22%
Year to Date
-76.03%
1 Year
-83.81%
Key Figures
0.437Open
0.489High
46.09KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.03%Turnover Ratio
0.433Prev. Close
0.424Low
20.30KTurnover
LossP/E Static
1.81P/B
0.00%Div Yield TTM
-108.32%ROA
3.65052wk High
0.06Volume Ratio
-243.79MNet Profit
187.90MShares
-1.3261EPS TTM
--Beta
-148.74%ROE
0.31552wk Low
15.01%Amplitude
--Gross Margin
80.61MMarket Cap
-0.28Reward/Risk
8.26%Risk Rate
More news coming soon, stay tuned...
Analyst Rating
Neumora Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.23/-0.24
Revenue / Forecast
--/0.00
Neumora Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolNMRA
Number of employees110
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Amgen Inc | 19.09% |
| ARCH Venture Partners | 18.27% |
| Invus Public Equities Advisors, LLC | 4.59% |
| Berns (Paul L) | 4.16% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 21.86% |
| Venture Capital | 19.33% |
| Corporation | 19.09% |
| Hedge Fund | 7.86% |
Related Instruments
+1.26%
+0.79%
+0.20%
+0.55%
+0.16%
+0.04%
-0.30%
+0.08%
+2.41%
+0.21%
-0.74%
+1.78%
+2.39%
-0.19%
+0.52%
+0.45%
-3.45%
+1.47%
+1.06%
-2.17%
FAQs
What is the current price of Neumora Therapeutics Inc (NMRA)?
The current price of Neumora Therapeutics Inc (NMRA) is 0.43.
What is the symbol of Neumora Therapeutics Inc?
The ticker symbol of Neumora Therapeutics Inc is NMRA.
What is the 52-week high of Neumora Therapeutics Inc?
The 52-week high of Neumora Therapeutics Inc is 3.65.
What is the 52-week low of Neumora Therapeutics Inc?
The 52-week low of Neumora Therapeutics Inc is 0.32.
What is the market capitalization of Neumora Therapeutics Inc?
The market capitalization of Neumora Therapeutics Inc is 80.61M.
Is Neumora Therapeutics Inc (NMRA) currently rated as Buy, Hold, or Sell?
According to analysts, Neumora Therapeutics Inc (NMRA) has an overall rating of Buy, with a price target of 4.67.
What is the Earnings Per Share (EPS TTM) of Neumora Therapeutics Inc (NMRA)?
The Earnings Per Share (EPS TTM) of Neumora Therapeutics Inc (NMRA) is -1.33.